Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ACAD
#1237
Acadia Pharmaceuticals Inc.
24.5
6
+1.24%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+1.24%
Monthly Change
-6.83%
6 month change
-7.08%
Year Change
+28.05%
Previous Close
24.2
6
Open
24.5
6
Bid
Ask
Low
24.5
6
High
24.5
6
Volume
140
Markets
US Stock Market
Healthcare
ACAD
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
160.05 M
161.2 M
162.23 M
164.77 M
166.79 M
170.49 M
—
Valuation ratios
Enterprise value
8.23 B
3.62 B
2.53 B
4.9 B
2.74 B
4.38 B
13.68 B
Price to earnings ratio
—
—
-12.18
-83.41
13.49
11.61
53.72
Price to sales ratio
—
—
0.01
0.01
3.19
—
—
Price to cash flow ratio
—
—
-0.02
0.3
19.36
41.32
97.09
Price to book ratio
—
—
0.01
0.01
4.17
3.7
7.12
Enterprise value to EBITDA ratio
-29.83
-22.27
-11.29
-61.66
7.43
—
—
Profitability ratios
Return on assets %
0.36
0.24
0.37
0.08
0.19
0.25
0.27
Return on equity %
0.45
0.31
0.54
0.14
0.31
0.32
0.36
Return on invested capital %
2 612.98
927.62
1 116.07
331.41
423.81
-90.92
6.7
Gross margin %
97.69
97.76
98.03
94.27
91.46
91.69
366.81
Operating margin %
64.87
35.2
43.23
10.1
24.1
9.78
39.09
EBITDA margin %
-62.46
-33.53
-43.37
-10.93
38.52
9.36
37.34
Net margin %
63.74
34.67
41.76
8.44
23.64
36.49
139.94
Liquidity ratios
Quick ratio
6.68
6.28
3.95
2.26
2.14
3.43
11.27
Current ratio
6.77
6.43
4.04
2.42
2.38
3.83
12.64
Inventory turnover
1.27
0.91
0.79
1.6
1.24
0.88
0.85
Asset turnover
0.56
0.65
0.8
1.09
0.99
0.78
0.85
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
0.71
0.1
0.95
0.65
0.65
EBIT per share
—
—
-1.38
-0.47
2.18
0.55
0.46
EBITDA per share
—
—
-1.39
-0.48
2.22
0.59
0.59
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
2.58
2.68
4.54
4.82
18.37
Net current asset value per share
—
—
3.14
3.76
5.64
6.25
23.45
Tangible book value per share
—
—
2.48
2.24
3.68
6.58
19.37
Working capital per share
—
—
2.36
2.21
3.27
4.62
15.97
Book value per share
—
—
2.48
2.64
4.4
7.22
22.04
ACADIA Pharmaceuticals Inc
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
News
ACAD Q4 Earnings Beat, Nuplazid & Daybue Drive Y/Y Revenue Growth
Jefferies raises Acadia Pharmaceuticals stock price target on guidance
Citizens raises Acadia Pharmaceuticals price target on growth outlook
ACADIA Pharmaceuticals Inc. (ACAD) Q4 2025 Earnings Call Transcript
ACADIA Pharmaceuticals Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:ACAD) 2026-02-25
Acadia Pharmaceuticals (ACAD) Q4 Earnings Top Estimates
ACADIA Q4 2025 slides: $1B revenue milestone as both drugs post double-digit growth
Wolfe Research initiates Acadia stock with outperform rating
This Rare Disease Biotech Name Teases Around A Buy Point
Acadia Pharmaceuticals stock rises on Mizuho upgrade
Mizuho upgrades Acadia Pharmaceuticals stock rating on remlifanserin potential
ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release